Older patients with STEMI and cardiogenic shock benefit from percutaneous coronary intervention
1. In this retrospective analysis of patients 75-years or older with ST-elevation myocardial infarction (STEMI) and cardiogenic shock, use of ...
Tag: STEMI
Low-dose intracoronary alteplase unlikely to improve outcomes in STEMI patients treated with primary PCI
1. In this randomized controlled trial, low-dose intracoronary alteplase given early during primary percutaneous coronary intervention (PCI) for acute ST-Elevation ...
Quick Take: Christmas, National Holidays, Sport Events, and Time Factors as Triggers of Acute Myocardial Infarction: SWEDEHEART Observational Study 1998-2013
Ischemic heart disease, the most common cause of morbidity and mortality worldwide, has many modifiable and non-modifiable risk factors, including ...
Reperfusion therapy may be suboptimal for STEMIs requiring transfers
1. Based on data from the Acute Coronary Treatment and Intervention Outcomes Network Registry–Get With the Guidelines (ACTION Registry-GWTG), only ...
Percutaneous intervention outcomes for STEMI similar for women and men
1. This meta-analysis of outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (STEMI) showed that women fared ...
Cardiac MRI predicts degree of heart dysfunction after STEMI
1. Using cardiac magnetic resonance imaging (MRI), an association was found between infarct severity in patients with reperfused ST segment ...
TASTE trial: Thrombus aspiration before PCI in STEMI does not reduce mortality
1. Patients with STEMI who underwent coronary artery thrombus aspiration before PCI did not have a significant reduction in mortality ...
The CLARITY trial: Adding clopidogrel to STEMI management [Classics Series]
Image: PD 1. The early addition of clopidogrel significantly reduced the incidence of infarct-related arterial re-occlusion within 30 days following ...
Bivalirudin during transport for primary PCI reduces major bleeding
Image: PD 1. Bivalirudin, initiated during transport for primary PCI in patients with STEMI, improved 30-day clinical outcomes with a ...
![Macitentan better than placebo for preventing progression of pulmonary arterial hypertension [SERAPHIN Trial]](https://www.2minutemedicine.com/wp-content/uploads/2013/08/ca68dc0329bef0b42ccae7b6656a0f_gallery-350x250.jpg)
2 Minute Medicine Rewind September 2 – September 8, 2013
Image: PD In this section, we will highlight the key high-impact studies, updates, and analyses published in medicine during the ...
